Patents by Inventor Sandeep Kumar Vashist

Sandeep Kumar Vashist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoassay for SARS-CoV-2 antibodies
    Patent number: 11703507
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: July 18, 2023
    Assignee: Pictor Limited
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko, Bhavesh Govind
  • IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
    Publication number: 20220163528
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Application
    Filed: July 29, 2021
    Publication date: May 26, 2022
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko Gilles, Bhavesh Govind
  • IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
    Publication number: 20220034904
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Application
    Filed: September 7, 2021
    Publication date: February 3, 2022
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko, Bhavesh Govind, Richard Janeczko
  • IMMUNOASSAY FOR SARS-CoV-2 ANTIGEN AND ANTIBODIES
    Publication number: 20220034886
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Application
    Filed: August 6, 2021
    Publication date: February 3, 2022
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko, Bhavesh Govind
  • Mediator-less Electrochemical Glucose Sensing Procedure Employing the Leach-proof Covalent Binding of an Enzyme(s) to Electrodes and Products Thereof
    Publication number: 20150122646
    Abstract: The present disclosure generally relates to devices and procedures for the development of glucose oxidase-bound electrodes by a covalent binding of glucose oxidase on amine-functionalized electrodes. More particularly, the present disclosure is related to covalently-bound enzyme-coated electrodes that are leach-proof and highly stable for continuous glucose monitoring. The glucose oxidase-bound electrodes are employed for the development of a mediator-less electrochemical glucose sensing procedure having no interference from biological substances and drugs.
    Type: Application
    Filed: May 3, 2013
    Publication date: May 7, 2015
    Inventors: Khalid Ali Al-Rubeaan, Dan Zheng, Fwu-Shan Sheu, Sandeep Kumar Vashist